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OBJECTIVES We conducted this study to assess long-term results of three-dimensional (3-D) mapping-
guided radiofrequency ablation (RFA) of inappropriate sinus tachycardia (IST). Change in
activation after the administration of esmolol was also assessed and compared to the shift
documented with successful sinus node (SN) modification.
BACKGROUND The long-term results after RFA of IST have been reported to vary between 27% and 66%.
METHODS Thirty-nine patients (35 women, mean age 31 9 years) with debilitating IST were included
in the study. The area around the earliest site of activation recorded using the 3-D mapping
system was targeted for ablation. The shift in the earliest activation site after administration
of esmolol was compared with the shift after RFA.
RESULTS The heart rate at rest and in drug-free state ranged between 95 and 125 beats/min (mean
99  14 beats/min). Sinus node was successfully modified in all patients. Following ablation,
the mean heart rate dropped to 72  8 beats/min, p  0.01. The extent of the 3-D shift in
caudal activation along the crista terminalis was more pronounced after RFA than during
esmolol administration (23  11 mm vs. 7  5 mm, respectively, p  0.05). No patient
required pacemaker implantation after a mean follow-up time of 32  9 months; 21% of
patients experienced recurrence of IST and were successfully re-ablated.
CONCLUSIONS Three-dimensional electroanatomical mapping seems to facilitate and improve the ablation
results of IST. The difference in caudal shift seen after esmolol administration and following
SN modification suggests that adrenergic hypersensitivity is not the only mechanism
responsible for the inappropriate behavior of the SN. (J Am Coll Cardiol 2002;39:
1046–54) © 2002 by the American College of Cardiology Foundation
Inappropriate sinus tachycardia (IST) is an uncommon
disorder that is associated with severe disability. Usually
patients with this rhythm problem have either an abnor-
mally high resting heart rate or a disproportionate increase
in heart rate in response to minimal activity (1,2). This
condition is predominantly encountered in women and is
clinically characterized by the occurrence of palpitation,
dizziness, shortness of breath, chest discomfort and occa-
sionally near syncope (3). It is generally differentiated from
atrial tachycardia, sinus node (SN) re-entry, compensatory
sinus tachycardia secondary to orthostatic hypotension or
other reversible conditions on the basis of the clinical and
electrocardiographic (ECG) findings, the electrophysiologic
study (EPS) and the absence of partial blood pressure drop
during tilt-table test (2,4,5).
Medical management of these patients includes beta-
blocker as the mainstay of therapy, and in patients refractory
to these drugs, catheter ablation aiming at either total
exclusion and obliteration or modification of the SN has
been described and performed (1,2). The initial experience
with a catheter-based approach was associated with low
success rate and a significant occurrence of complete de-
struction of the SN, necessitating permanent pacemaker
implantation (6–8). In this respect, a clear definition and
identification of the anatomic target to avoid complete
destruction of the SN is needed. Recently, a more accurate
electrophysiologic and anatomic localization of SN has been
obtained combining endocardial mapping of the earliest site
of activation with intracardiac echocardiography (9–11).
But this approach, as reported by Shinbane and Scheinman
(12), is associated with a recurrence rate of 77%. This could
be explained by the inability to combine the global activa-
tion of the SN with the anatomic localization of this
structure.
The purpose of this study was to evaluate the long-term
efficacy and safety of the three-dimensional (3-D) nonfluo-
roscopic mapping and navigation system in the treatment of
IST. We also assessed the effect of beta-receptor blockers on
the IST during the ablation procedure. Moreover, we
compared the psychological status of the patients before and
after successful IST ablation.
METHODS
Patient population. Thirty-nine patients diagnosed with
IST were included in this study. All patients had documen-
tation of their arrhythmia, either by Holter monitor or loop
recorder, during which correlations between symptoms and
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the arrhythmia were documented. Thirty-three of these
patients were previously treated with beta-blockers alone or
in combination with calcium antagonists without any suc-
cessful control of their arrhythmia. The remaining six
patients elected to consider this procedure as an alternative
to long-term antiarrhythmic treatment. Each patient under-
went exercise treadmill test before and one month after the
procedure. Twenty patients underwent daily monitored
aerobic exercise for two months before being considered for
this procedure. Both the definition and the diagnosis of IST
were based on standard criteria. Patients were excluded from
this series if they had previous ablation of the SN in other
centers, or if their follow-up was shorter than two years, and
if they experienced postural orthostatic tachycardia associ-
ated with the IST symptoms.
Electrophysiologic study. Each patient signed a written
informed consent. Antiarrhythmic medication was discon-
tinued at least 5 half-lives before the EPS. Patients were
studied in the postassortative state. Sedation with intrave-
nous fentanyl and midazolam was achieved. Instrumenta-
tion consisted of multielectrode catheters placed in the right
atrium and His-bundle position via the right femoral vein.
Coronary sinus recordings were performed from a 6F
decapolar catheter (2–5–2-mm interelectrode spacing; Daig,
Minnetonka, Minnesota) advanced through the right inter-
nal jugular vein. A 7F deflectable 4-mm tip quadripolar
catheter (Biosense Webster, Diamond Bar, California) was
used for atrial mapping and ablation.
Mapping of the right atrial activation was performed in a
drug-free state during isoproterenol infusion at 2 g/min. If
isoproterenol was unable to reproduce the tachycardia,
intravenous aminophylline was given at a dose of 6 mg/
kg/20 min followed by maintenance infusion of 0.5 mg/kg
per min. Programmed electrical simulation was performed
before and after the ablation procedure to verify the mech-
anism of the arrhythmia and to exclude the coexistence of
other arrhythmias.
Autonomic testing. In 10 patients with a resting heart rate
faster that 100 beats/min the response to esmolol infusion
was assessed before ablation. In addition, the shift of the
earliest SN activation site during esmolol infusion and after
successful ablation was compared. Esmolol was adminis-
tered at an infusion rate of 500 g/kg per min for 5 min
followed by 300 g/kg per min. After 15 min of esmolol
maintenance infusion rate, 3-D right atrial mapping was
repeated.
Exercise treadmill test and pre-procedure aerobic training.
An exercise treadmill test using the Bruce protocol was
performed in all patients before and one month after
successful ablation. In the first 20 patients, a regimen of two
months of intensive monitored aerobic exercise, including
20 to 40 min of vigorous activity five days/week, was
prescribed before the ablation.
Intracardiac echocardiography. In eight patients intracar-
diac echocardiography (ICE) was obtained to verify the
ability of the nonfluoroscopic mapping system to identify
the crista terminalis (CT). A 10-MHz ultrasound trans-
ducer mounted on the tip of an 8.5F catheter (Boston
Scientific, Sunnyvale, California) was used to visualize the
CT. The ICE catheter was advanced in the right atrium
using a long sheath (8.7F inner diameter/11F outer diam-
eter) with a preshaped curve chosen based on the patient’s
right atrial anatomy so as to facilitate advancement of the
intracardiac probe in the proximity of the CT. The CT
points were initially identified and tagged on the electro-
anatomical map obtained with the CARTO system (Fig. 1);
the validity of those sites was then verified by correlation
with the information obtained using the ICE probe.
Intracardiac 3-D nonfluoroscopic mapping system. The
3-D electroanatomical mapping system has been described
previously (13). Briefly, it consists of an electromagnetic
location pad positioned under the patient’s back, a CARTO
processor unit (Biosense Webster), a Silicon Graphics
workstation and an electromagnetic sensor-equipped cath-
eter. This catheter was used for navigation mapping and
ablation.
A 3-D electroanatomical map was created during sinus
rhythm in the drug-free state, after administration of
esmolol, during infusion of isoproterenol and/or aminoph-
ylline and after ablation resulted in change of heart rate. To
reduce the risk of phrenic nerve damage on each map, the
sites where phrenic nerve stimulation was demonstrated
were tagged (Fig. 1). Ablation was performed starting at the
earliest site of activation and extended for about 5 mm in
each direction. Any drop in heart rate was followed by
acquisition of a new right atrial 3-D map. Energy delivery
was discontinued if no SN acceleration was seen within 10 s.
If SN acceleration was not seen during ablation at the
earliest activation site, the catheter was moved cranially first
and subsequently caudally, looking for the sites where
ablation would result in SN acceleration. When shift in the
earliest site of activation was observed, and if further
ablation was required owing to insufficient drop of the heart
rate, ablation was performed at the superior edge of the new
earliest activation site before moving to caudal locations.
Ablation was terminated if the heart rate dropped below
120 beats/min during isoproterenol infusion at 2 g/min
alone or in combination with aminophylline infusion. This
heart rate end point was established based on the upper
heart rate observed in 15 normal volunteers receiving the
Abbreviations and Acronyms
CT  crista terminalis
ECG  electrocardiogram/electrocardiographic
EPS  electrophysiologic study
ICE  intracardiac echocardiography
IST  inappropriate sinus tachycardia
RFA  radiofrequency ablation
SN  sinus node
3-D  three-dimensional
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Figure 1. Three-dimensional electroanatomic activation map (CARTO) of the right atrium showing the ability to tag anatomical structure relevant to the
ablation procedure. (A) Right anterior oblique view of the right atrium during inappropriate sinus tachycardia. The gray tags represent sites where pacing
was able to stimulate the phrenic nerve. Green tags reproduce the course of the crista terminalis. (B) The same activation map as in A, but in a more
posteriorly rotated view. Continued on next page.
same dose of isoproterenol. When the end point was
achieved, a 3-D map of the right atrium was re-created. If
no recovery of the heart was observed 45 to 60 min after last
radiofrequency application was delivered, the procedure was
then terminated.
Follow-up. After ablation, all patients were seen in the
outpatient clinic at one month and every four months
thereafter. In addition to a 24-h Holter monitoring, at each
follow-up a 12-lead ECG was obtained. In case of recur-
rence of symptoms, the patient was monitored with a loop
recorder for four weeks.
Twenty-four patients had direct access to medical per-
sonal 24 h a day and were encouraged to contact them
should symptoms recur. The remaining 15 patients were
seen in the outpatient clinic based on the schedule previ-
ously mentioned. At one-year follow-up, each patient was
asked to assess the benefit of the ablation on a scale from 0
(absent) to 5 (very good).
Statistical analysis. Data are presented as mean  SD.
Paired and unpaired t-tests were used to compare the pre-
and postablation categorical variables. The chi-square test
was used to compare noncategorical variables. A p value
0.05 was considered statistically significant.
RESULTS
Patient population. Thirty-nine patients were included in
this study (35 women, 4 men; mean age 31 9 years; range,
22 to 44 years). All patients had debilitating IST with no
evidence of other identifiable causes for this arrhythmia,
including postural orthostatic tachycardia syndrome. Symp-
toms associated with sinus tachycardia were present in all
patients for at least three months. Two patients had under-
gone previous atrioventricular junctional ablation and place-
ment of a permanent VVIR pacemaker without improve-
ment of their symptoms. Both patients subsequently
developed pacemaker syndrome. Of the 39 patients, 18 had
persistent sinus tachycardia with a rate 100 beats/min
(mean 125  10 beats/min) and 21 patients had daily
multiple paroxysmal episodes. None of the patients had
evidence of structural heart disease. The heart rate at rest
and in a drug-free state ranged between 95 and 125
beats/min (mean 99  14 beats/min).
In the 20 patients undergoing aggressive aerobic exercise
for two months before the procedure, the resting heart rate
significantly dropped (108  12 beats/min, vs. 96  14
beats/min, p  0.05), but the multiple daily episodes of
Figure 1. (continued). (C) The caudal shift of the earliest activation site following sinus node modification.
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Figure 2. Three-dimensional electroanatomic activation map (CARTO) of the right atrium. Spontaneous sinus tachycardia is shown after administration
of esmolol (B) and following successful sinus node modification (C). Continued on next page.
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paroxysmal sinus tachycardia were still present and unre-
sponsive to drugs.
Electrophysiologic findings. Inappropriate sinus tachycar-
dia occurred spontaneously after administration of 2 g/min
isoproterenol infusion in 35 patients and 6 mg/kg per 20
min of aminophylline in 4 patients. Before ablation of IST,
different types of atrial arrhythmias were excluded. During
infusion of 2 g/min of isoproterenol and/or aminophylline,
the heart rate increased to a mean of 160  28 beats/min
(range, 145 to 190 beats/min) and 150  25 beats/min
(range, 130 to 180 beats/min), respectively.
Mapping and ablation results. In all patients the 3-D
electroanatomical map during isoproterenol and aminoph-
ylline infusion showed a cranial shift as compared to the
drug-free state, ranging from 5 mm to 14 mm (mean 9 
4 mm). Administration of esmolol in 10 patients with heart
rate faster than 100 beats/min, in drug-free state, showed a
caudal shift of the earliest activation site ranging between 5
and 20 mm (mean 7  5 mm). In all 10 patients the extent
of the 3-D–documented shift in caudal activation along the
CT was more pronounced after radiofrequency ablation
(RFA) compared to the shift in activation during esmolol
administration (23  11 mm; range, 20 to 45 mm, p 
0.05) (Fig. 2).
The caudal shift of the right atrial activation seen with
the procedural end point was associated with flattening of
the P-wave in the inferior lead and occasionally (three
patients) with slightly negative initial component of the
P-wave in the same ECG recordings. In none of the
patients were asystole or sinus pauses observed during
ablation. To achieve successful SN modification in 10 of 39
patients, an 8-mm tip ablation catheter (EP Technologies,
Sunnyvale, California) was required. In two additional
patients a cooled-tip catheter (Cardiac Pathways, Sunny-
vale, California) was used to achieve successful modification
of the SN. When either the 8-mm tip or the cooled-tip
catheter was used for delivery of energy, the CARTO 4-mm
tip catheter was used as a guide to the earliest ablation site
of activation. The mean intracardiac ECGs amplitude
recorded in the SN area was similar among patients requir-
ing ablation with cooled-tip and 8-mm tip catheters, and
patients ablated with a 4-mm tip electrode (4-mm 1.6 
0.4 mV vs. cooled/8-mm 1.7  0.6 mV, p  NS). In eight
patients (21%) the ablation site resulting in drop of the heart
rate was away from the earliest activation site by a mean of
7  3 mm. The successful site was indeed caudal to the
earliest site in six of the eight patients and cranial to the
earliest site in two of the eight patients.
Figure 2. (continued) Red represents early and purple represents late electrical atrial activation. (A) The earliest site of activation during inappropriate sinus
tachycardia (IST) to be in the vicinity of the atrium-SVC junction. (B) A 3.5-cm caudal shift of the earliest activation site after administration of intravenous
esmolol. A CARTO map after sinus node modification shows a 2.5-cm caudal shift in the earliest activation site along the crista terminalis. CS  coronary
sinus; HIS  His-Bundle potential; SVC  superior vena cava; IVC  inferior vena cava; TV  tricuspid annulus.
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In two patients, to achieve rate drop, lesions had to be
delivered at sites showing capture of the phrenic nerve. In
one patient, the pacing threshold was 9 mA, and ablation
did not damage the nerve. In the second patient, the pacing
threshold was 4 mA, and ablation induced diaphragm
paralysis, which recovered seven months after the procedure.
After successful SN modification, the mean heart rate was
72  8 beats/min (range, 65 to 87 beats/min) in drug-free
state, and 105  12 beats/min (range, 99 to 115 beats/min)
on 2 g/min of isoproterenol infusion.
The mean number of lesions and fluoroscopy times were
29  11 min and 21  6 min, respectively. The mean
length of the area covered by ablation lesions at the end of
the procedure was 12  4 mm times 19  5 mm.
Associated arrhythmias. In 12 of 39 patients (31%) other
tachyarrhythmias were induced either at the end of the
initial study or were observed at follow-up in association
with recurrence of palpitation. In nine patients following
ablation of IST, the AV node re-entry (three patients), right
atrial tachycardia (four patients) and left atrial tachycardia
(two patients) were documented and successfully ablated. In
three patients, symptoms recurring 3  1 months after
follow-up were associated with documented tachycardia,
which revealed a P-wave morphology different from the
sinus rhythm P-wave. Left atrial tachycardia originating
along the anterosuperior aspect of the mitral annulus was
mapped in all three patients and successfully ablated. Of
these three patients, only one patient has sustained repeti-
tive episodes of atrial tachycardia at the time of the EPS and
ablation, whereas in the other two patients, mapping of
frequent isolated beats (one patient) and nonsustained short
episodes of this tachycardia (one patient) were mapped and
ablated.
Follow-up findings. At follow-up, ambulatory ECG mon-
itoring and exercise stress test showed a significant reduc-
tion of the sinus rate as compared to the procedure before
assessment. As shown in Table 1, the mean heart rate at 1.5
min of exercise dropped to 96  7 beats/min after ablation
from a mean of 157  11 beats/min before ablation (p 
0.001). Similarly, following ablation, the mean maximal
heart rate with exercise dropped to 125  9 beats/min from
178 15 beats/min before ablation (p 0.001). All Holter
monitoring variables before ablation were altered and sig-
nificantly reduced in the postablation assessment (Table 1).
Eight patients (21%) had recurrence of IST and required
repeat ablation. Inappropriate sinus tachycardia recurred
within one to three weeks after the initial ablation (18  10
days). As mentioned previously, three additional patients
had recurrence of symptoms after successful SN modifica-
tion, and repeat EPS demonstrated left atrial tachycardia
that was successfully ablated. Therefore, 28% of the patients
(11 of 39 patients) required a second procedure. Two of the
patients undergoing SN modification had a pacemaker
previously implanted, which was upgraded after the initial
procedure to a dual-chamber device. One of these two
patients experienced symptoms compatible with superior
vena cava syndrome four months after the procedure.
Further investigations including transesophageal echocardi-
ography and a venous angiogram showed the presence of a
stricture with a gradient at the junction between the
superior vena cava and the right atrium. Balloon dilation in
this patient resulted in complete resolution of her symp-
toms.
After a successful procedure, 17 patients (44%) reported
persistence of symptoms of palpitation, shortness of breath,
chest pain and near syncope. Monitoring with a loop
recorder did not show any recurrence of IST. In 7 of 17
patients, premature ventricular (5 patients) or atrial (2
patients) contractions were documented with symptoms.
After counseling for several months, 10 of these 17 patients
had improvement of their symptoms. Near syncope consis-
tent with neurocardiogenic episodes was present in seven
patients and was pre-existent to the ablation.
At the one-year follow-up, patients scored the overall
impact of the ablation as poor (2 patients), fair (12 patients),
good (17 patients) and very good (8 patients). Complete
resolution of symptoms was more likely to occur in patients
with a shorter history of tachycardia (median duration of 3
months [range 3 to 7 months] vs. 24 months [range 14 to 70
months], p  0.05). In addition, the percentage of patients
reporting presence of syncope or near syncope, severe chest
pain or shortness of breath before ablation was higher
among those perceiving the procedure as poor or fair, versus
good or very good (poor/fair group, 12 of 14 [86%] vs.
good/very good group, 5 of 25 [20%], p  0.01).
After ablation, 15 of 39 (38%) patients were followed
with clinic visits scheduled as per routine postablation
protocol (group 1). The remaining 24 (61%) patients
instead had direct access to allied professionals 24 h a day
for counseling and medical advice (group 2). In the group
with direct access to allied professionals the median monthly
number of emergency room admissions or clinic visits was
drastically reduced after ablation, whereas no difference was
seen in the group undergoing conventional follow-up in the
outpatient clinic. In the group with direct access to allied
professionals, the median number of phone contacts during
the first months of postablation was four (between two and
six) and appeared to drop over time, with the median
number three months after ablation equal to zero (from zero
Table 1. Changes in Heart Rate Before and After Ablation
Preablation HR
(beats/min)
Postablation HR
(beats/min) p Value
Holter monitor
Mean HR 108  5 85  5  0.001
Maximum HR 182  6 120  4.2  0.0001
Minimum HR 88  5 61  4.3  0.01
Exercise test
Resting HR 99  4 72  4.1  0.001
Mean HR after
1.5 min
157  11 96  7  0.001
Maximum HR 178  15 125  9  0.001
HR  heart rate.
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to one). Only two of the patients followed by direct access
to an allied professional required unscheduled visit postsuc-
cessful ablation. In contrast, in the group undergoing
conventional follow-up, the number of clinic visits or
emergency room admissions during the first month after
ablation was similar to the number observed before ablation
(Table 2). A psychiatrist assessed all patients before and at
least six months after successful ablation. Before ablation, 2
patients were diagnosed with schizophrenia, 3 with depression,
21 with panic disorder and 13 with somatoform disorders.
Following ablation, 18 of 21 patients (81%) with panic
disorder did not continue their follow-up in the psychiatric
clinic. Four of the patients with panic disorder continued to
take antianxiety medications intermittently, and 10 experi-
enced sporadic episodes of shortness of breath and chest pain.
In addition, 8 of the 13 patients (61%) with a diagnosis of
somatoform disorder also discontinued their psychiatric clinic
follow-up and did not require any further psychiatric care.
After a mean follow-up of 32  9 months all patients
remained in sinus rhythm without any evidence of inappro-
priate behavior of the SN response during exercise and daily
activity.
DISCUSSION
Main findings. We demonstrated that 3-D electroana-
tomical mapping of the right atrium provides an effective tool
to monitor and guide ablation for IST. This approach seems to
eliminate the occurrence of excessive destruction of the SN and
to reduce and perhaps eliminate the risk of complete SN
ablation. Moreover, we could demonstrate that IST is fre-
quently associated with other entities of atrial tachyarrhyth-
mias.
Previous studies. Previously, studies on radiofrequency
catheter ablation of IST have reported a wide range of
long-term success rates (from 23% to 66%) and a sizable risk
of complete abolition of the SN (1,2,7,8,14). Recently, Man
et al. (1) have shown modification of the SN using conven-
tional mapping technique to be modestly effective in man-
aging patients with IST. As reported by Man et al. (1), one
of the factors contributing to the limited long-term cure was
the inability to target with precision the sites of impulse
origin using conventional mapping. Recently, RFA guided
by ICE has also appeared to reduce the risk of inadvertent
SN damage (9–12). However, this technique seems to be
associated with a poor success rate (23%) at the long-term
follow-up (12). One must realize that SN modification is
not a focal ablation, but requires complete abolition of the
cranial portion of the SN complex, which seems to show
automatic behavior. With the 3-D electroanatomic map-
ping system we could define the sites of earliest activation
with accuracy, and a more systematic ablation around the
area of the cranial portion of the SN was easy to achieve by
using the real-time electroanatomic mapping and navigation
features. This may have been responsible for the better
follow-up results observed in our series compared to those
reported by Man et al. (1) and Shinbane and Scheinman
(12).
Conversely, in about 20% of the patients the site where
ablation resulted in successful SN modification did not
correspond to the area of earliest activation. This suggests
that at times the earliest activation represents the endocar-
dial exit point into the right atrium of SN firing cells located
deeper within the SN structure. It is also important to
appreciate the proximity between the ablation sites and the
SN exit point after the ablation. This supports the need of
an accurate, continuous and real-time monitoring of the
ablation location to avoid inadvertent damage to the area of
the SN relevant for the long-term physiologic SN function.
Association with other arrhythmias. Of importance is the
recognition of the relatively frequent association with other
atrial tachycardias, which required ablation to maximize
procedural success. Several of these tachycardias, although
clinically sustained, appeared nonsustained in the electro-
physiology laboratory.
Response to beta-blockade. Of interest is the response to
beta-blockade before ablation. Morillo et al. (15) suggested
that the mechanism leading to IST is related to a primary
SN abnormality characterized by a high intrinsic heart rate,
depressed efferent cardiovagal reflex and beta-adrenergic
hypersensitivity. Our data are consistent with a combined
mechanism involving both an increased sympathetic hyper-
sensitivity and an intrinsic automatic behavior. Indeed, the
caudal shift observed after beta-blockade with esmolol was
less drastic than the shift seen after successful ablation. This
supports the concept that adrenergic hypersensitivity is not
the only mechanism responsible for the inappropriate be-
havior of the SN in these patients.
Similarly, monitored aerobic exercise despite reducing the
resting heart rate did not abolish inappropriate paroxysms of
sinus tachycardia, suggesting again that both increased
adrenergic response and automatic behavior coexist in the
majority of patients with IST. Previously, preliminary re-
Table 2. Patients’ Characteristics and Hospitalization or Clinic
Visits During Follow-Up
Group 1
(15 patients)
Group 2
(24 patients)
p
Value
Age 29  16 25  11 NS
Gender (F/M) 23/2 22/2 NS
Psychiatric diagnosis 100% (15/15) 100% (24/24) NS
Mean duration of symptoms
(months)
20  5 22  5 NS
Median monthly number of ER
or clinic visits preablation
(range)
3 (2–6) 3 (1–5) NS
Median number of ER or clinic
admissions 1-month
postablation (range)
0 (0–2) 3 (2–5)  0.05
Median number of phone contacts
1-month postablation (range)
4 (2–6) 1 (1–2)  0.05
Median number of phone contacts
during the third month
postablation (range)
0 (0–1) None  0.05
ER  emergency room.
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sults from our laboratory have shown that teenagers repre-
sent a selected group of subjects with IST who may respond
to the aerobic exercise program (16). It is conceivable that
very young patients share a different mechanism with a
predominant hyperactivity of the sympathoadrenergic sys-
tem. In eight patients (21%) of our series to achieve
persistent SN modification, the use of an 8-mm tip or a
cooled-tip catheter was required. It is possible that in a small
number of patients the thickness of the area of interest may
prevent successful ablation with conventional approaches
and thus require the need of ablation techniques allowing
for larger and deeper lesions.
Psychological impact of ablation. The personality of pa-
tients with IST is complex, and it is therefore important to
discuss thoroughly the realistic expectations and beneficial
effects of the procedure. Many of our study patients had
associated psychiatric disorders, which improved following
ablation in about 66% of them.
In contrast, in the majority of patients symptoms of
shortness of breath and chest pain persisted after successful
elimination of the rhythm problem. In this respect, patients
more likely to experience a complete resolution of their
symptoms are those with a shorter history of the arrhythmia.
Conversely, patients reporting near syncope, syncope, and with
a longer history of IST had a higher probability of recurrent
complaints after the procedure. Because of the high incidence
of associated symptoms, in these patients easy access to medical
personnel appeared to be beneficial after ablation in reducing
the utilization of health-care resources. In fact, direct access to
allied health professionals in a group of the patients included in
this series reduced the need for emergency room visits and
unscheduled clinic visits after the ablation procedure.
Conclusions. Finally, 3-D electroanatomic-mapping–
guided SN modification is effective and safe. Moreover,
adrenergic hypersensitivity does not appear to be the only
mechanism responsible for IST. In addition, our study
provides information that is relevant to counsel patients
considered for SN modification regarding the realistic
expectations from the procedure. As it appeared from our
results, patients with absence of symptoms other than
palpitation and early ablation after presentation of the
rhythm disorder were more likely to perceive the procedure
as beneficial and to experience complete symptom resolu-
tion. After ablation, counseling and easy access to experi-
enced allied professionals increase the positive impact of this
procedure on the use of health-care resources.
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